Evolution of Omega-3 Fatty Acid Therapy and Current and Future Role in the Management of Dyslipidemia

This publication has 44 references indexed in Scilit:

• Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study
  Vascular Health and Risk Management, 2013
• Icosapent Ethyl, a Pure Ethyl Ester of Eicosapentaenoic Acid: Effects on Circulating Markers of Inflammation from the MARINE and ANCHOR Studies
  American Journal of Cardiovascular Drugs, 2013
• Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study)
  The American Journal of Cardiology, 2012
• Omega-3 Fatty Acids and Cardiovascular Disease
  JACC, 2011
• Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
  New England Journal of Medicine, 2010
• Meta-analysis of Comparative Efficacy of Increasing Dose of Atorvastatin Versus Rosuvastatin Versus Simvastatin on Lowering Levels of Atherogenic Lipids (from VOYAGER)
  The American Journal of Cardiology, 2010
• Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome
  Diabetes Care, 2009
• Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators
  European Heart Journal, 2008
• Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women
  JAMA, 2007
• Antiarrhythmic Effects of Omega-3 Fatty Acids
  The American Journal of Cardiology, 2006